Best Demy Colton Podcasts (2025)

1
Policy Pressure: Communicating at the Speed of Change 1:03:59

Play Pause

22d ago1:03:59

1:03:59

Briefing Room Virtual Salon Series Policy Pressure: Communicating at the Speed of Change As policy shifts reshape the landscape of science and innovation, communications teams are under pressure to adapt—fast. From drug pricing reforms to changing regulatory expectations to rapidly evolving funding landscapes, the stakes for how biotech and pharma …

1
Spotlight Panels: A New Way to Maximize Visibility for Innovative Biotech Companies 1:09:54

2M ago1:09:54

1:09:54

In this episode, we’re bringing you highlights from a virtual salon focused on one of the biggest challenges for biotech companies, telling your story in a way that attracts funders and partners. You’ll hear advice straight from investors, communication experts, and pharma BD leaders on what resonates and why. This hour-long conversation also intro…

1
Fireside Chat with Mike Gaito, Global Head of Healthcare Investment Banking, JP Morgan 1:15:15

2M ago1:15:15

1:15:15

Moderator: Dennis Purcell, Founder, Aisling CapitalBy Demy-Colton

1
The Future of Healthcare 45:18

2M ago45:18

45:18

Two industry titans explore the metamorphosis that is unfolding in health care, driven by innovation and demanded by consumers, that will profoundly transform this space as we know it.By Demy-Colton

1
Drugging the UnDruggable 55:51

2M ago55:51

55:51

Up to 85% of the human proteome is considered “undruggable,” with proteins that lack the pockets where traditional therapeutics can bind. But that barrier is beginning to shift. A new wave of biotech companies is bringing forward breakthrough technologies designed to target the most elusive proteins—opening the door to therapies once thought imposs…

1
Alzheimer's 53:29

2M ago53:29

53:29

Alzheimer’s disease is a relentless and fatal illness, creating a profound health crisis for patients, families, and societies worldwide. Without meaningful progress, the societal costs will be staggering. Global thought leaders have set an ambitious goal: to develop a treatment that can slow the progression of Alzheimer’s by 2025. While late-stage…

1
The Fusion of Technologies 1:13:32

2M ago1:13:32

1:13:32

In this episode, we sit down with Amy Abernethy, Principal Deputy Commissioner of the U.S. Food & Drug Administration, for a candid conversation on disruption in healthcare. We’ll explore how COVID has accelerated change across the system, and whether that disruption is ultimately driving positive transformation for patients, providers, and innovat…

1
Bioelectric Medicine 1:20:17

2M ago1:20:17

1:20:17

Electricity has long been used as a therapeutic tool to restore heart rhythms, stimulate nerves and neurochemicals, and even support cellular regeneration. Today, innovation in this field is accelerating, with new medical devices and bioelectrical treatments emerging for conditions ranging from CNS diseases to cancer and diabetes. In this episode, …

1
Fundraising for the EU Market 1:22:48

2M ago1:22:48

1:22:48

Fundraising has long been a challenge for European biopharma companies, particularly those moving programs into the clinic, due to the limitations of European public markets. But change may be on the horizon. With the rise of virtual fundraising, European innovators are finding new opportunities to access ex-EU public and private capital. But is th…

1
To Launch or Out-License in Europe? 1:14:06

2M ago1:14:06

1:14:06

European commercialization may look daunting at first, 30 EEA countries plus the UK and Switzerland, a population of 370 million, multiple regulatory systems, diverse reimbursement environments, labor laws, and a rich mix of languages and cultures. That’s why this session is essential for any CEO weighing Europe as a strategic option. While the cha…

1
Three Strategies For Attracting Early-Stage Investment 1:17:58

2M ago1:17:58

1:17:58

Nearly 80% of new biopharmaceutical projects are now originating from academia and small-to mid-sized companies. These emerging players face significant challenges as they work to advance promising new therapies. Whether the goal is to out-license, commercialize, or position for acquisition, success often hinges on early investment, from fully inte…

1
Series 3: Nuances of Market Access – Future-Proofing 1:20:15

2M ago1:20:15

1:20:15

Part 3 takes on the evolving market access landscape in the dynamic U.S. healthcare system. With value delivery at the forefront, this discussion examines how companies can measure and demonstrate value, the critical interplay between FDA and CMS on value propositions, and practical strategies for engaging payers.…

1
Series 2: Nuances of Market Access – Making it Real 1:16:19

2M ago1:16:19

1:16:19

In Part 2, we build on the foundations from our first series with a series of real-world hypotheticals that highlight why and how developers can create a market access strategy early in clinical development. This conversation explores strategies around clinical trial design, anticipating investor questions, and strengthening competitive positioning…

1
Series 1: Nuances of Market Access - The Foundation 1:19:28

2M ago1:19:28

1:19:28

In our first series, we set the stage with a deep look at the government and commercial payer landscape, covering coverage, reimbursement, and pricing, and how these factors can shape commercialization strategy in real time. While many business considerations around commercialization are well understood, this discussion shines a light on the legal …

1
Market Access and Valuation: Key Considerations for Multi-Indication Products 1:18:37

2M ago1:18:37

1:18:37

Join us for an episode featuring a distinguished panel of experts as they dive into pricing and deal valuation dynamics for multi-indication products. The conversation explores the key questions commercialization partners, acquirers, and capital providers ask when evaluating both multi-indication and platform products for deal valuation. Hear first…

1
The Power of Presenting at Biotech Showcase: Unlocking Investor Interest and Strategic Partnerships 1:15:19

2M ago1:15:19

1:15:19

In this dynamic and insightful episode, we bring together a diverse group of industry leaders to explore the art and science of successful presentations at Biotech Showcase. As one of the largest and most influential healthcare investor conferences, Biotech Showcase takes place during Healthcare week in San Francisco and offers unparalleled opportu…

1
2025 TechBio Investor and Technology Trends at Biotech Showcase During Healthcare Week 1:16:53

2M ago1:16:53

1:16:53

Tune in for an insightful webinar featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of human health during Biotech Showcase and Healthcare Week in San Francisco. This episode will provide valuable updates on what to expect from the TechBio sector, includin…

1
A Conversation with Tim Opler: Navigating the Biotech Financial Markets in 2025 1:08:18

2M ago1:08:18

1:08:18

Join us for an insightful conversation, featuring Tim Opler, as we explore the evolving landscape of the biotech financial markets in 2025. As we enter a new era characterized by growth, complexity, and opportunity, the sector faces a myriad of challenges and advancements. With a new government in place, rapid technological innovations, shifting re…

1
Women's Health Moves Mainstream – Rapid Growth Meets Underserved Market 1:18:46

2M ago1:18:46

1:18:46

The rapidly growing “Femtech” market is expected to grow to $50B by 2025. Hear from this group of leading private company CEOs, who are heading up innovative advances in technology, that could change the way women's health is treated. The panelists will share perspectives on high-potential investment areas within the space. Learn how these CEOs sec…

1
Runway Extension In Difficult Times 1:10:34

2M ago1:10:34

1:10:34

Runway extension in these turbulent times does not only apply to start ups but also to long established companies. What strategies can you employ to extend your company’s cash runway? What revenue streams should you pursue, IPOs, Private Equity, Venture, Debt, SPACs, PIPEs, partnering? How can you prevent overspending or running out of capital enti…

1
VC Trends in Healthcare Investing:  Current Pulse Check 1:17:36

2M ago1:17:36

1:17:36

Dive into the insights of leading VC investors as they discuss the current life sciences investment landscape. Panelists will discuss technology-driven convergence and its impact on the pharmaceutical and biotech sectors. Are crossover rounds making a comeback? These VC partners will delve into what is currently driving their investment decisions, …

1
Increasing The Stakes: Creating and Selling Your Valuation Story in Changing Times 1:13:04

2M ago1:13:04

1:13:04

Immune therapies and obesity treatments are getting lots of attention, and many pundits would tell you platform strategies and gene therapies have fallen out of favor. And while the Biotech Index has rebounded almost 50% from its October 2023 low, many companies are still struggling to fundraise. Our outstanding group of panelists will help distill…

1
Trendwatching for Early-Stage TechBio Companies 1:16:53

2M ago1:16:53

1:16:53

Join us for an insightful episode featuring a panel of TechBio CEOs, venture investors, and industry experts as they discuss the latest trends and innovations shaping the future of human health during Biotech Showcase and Healthcare Week in San Francisco. This session will provide valuable updates on what to expect from the TechBio sector, includin…

1
The Science of Longevity 1:07:48

2M ago1:07:48

1:07:48

In this episode, we’re joined by Tim Opler, PhD, of Stifel, and Lila Taylor of Demy-Colton for a deep dive into the science of longevity. Together, they share insights on how breakthroughs in genetics, cellular biology, and regenerative medicine are moving from the lab into real therapies aimed at slowing or even reversing the effects of aging. We’…